Plasma Renin Activity and Aldosterone Concentrations in Hypertensive Cats with and without Azotemia and in Response to Treatment with Amlodipine Besylate
Open Access
- 1 January 2014
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 28 (1) , 144-153
Abstract
Background: Role of renin-angiotensin aldosterone system (RAAS) in feline systemic hypertension is poorly understood. Objectives: Examine plasma renin activity (PRA) and plasma aldosterone concentrations (PAC) in normotensive and hypertensive cats with variable renal function and in response to antihypertensive therapy. Animals: One hundred and ninety-six cats >9 years from first opinion practice. Methods: PRA, PAC, and aldosterone-to-renin ratio (ARR) were evaluated in cats recruited prospectively and grouped according to systolic blood pressure (SBP) and renal function (nonazotemic normotensive [Non-Azo-NT], nonazotemic hypertensive [Non-Azo-HT], azotemic normotensive [Azo-NT], azotemic hypertensive [Azo-HT]). Changes in PRA and PAC were evaluated with antihypertensive therapy (amlodipine besylate). Results: Plasma renin activity (ng/mL/h; P = .0013), PAC (pg/mL; P < .001), and ARR (P = 0.0062) differed significantly among groups. PRA (ng/mL/h) was significantly lower in hypertensive (Non-Azo-HT; n = 25, median 0.22 [25th percentile 0.09, 75th percentile 0.39], Azo-HT; n = 44, 0.33 [0.15, 0.48]) compared with Non-Azo-NT cats (n = 57, 0.52 [0.28, 1.02]). Azo-HT cats had significantly higher PAC (n = 22, 149.8 [103.1, 228.7]) than normotensive cats (Non-Azo-NT; n = 26, 45.4 [19.6, 65.0], Azo-NT; n = 18, 84.1 [38.6, 137.8]). ARR was significantly higher in Azo-HT (n = 20, 503.8 [298.8, 1511]) than Azo-NT cats (n = 16, 97.8 [77.0, 496.4]). Significant increase in PRA was documented with antihypertensive therapy (pretreatment [n = 20] 0.32 [0.15–0.46], posttreatment 0.54 [0.28, 1.51]), but PAC did not change. Conclusions and Clinical Importance: Hypertensive cats demonstrate significantly increased PAC with decreased PRA. PRA significantly increases with antihypertensive therapy. Additional work is required to determine the role of plasma aldosterone concentration in the pathogenesis of hypertension and whether this relates to autonomous production or activation of RAAS without demonstrable increase in PRA.Keywords
Funding Information
- The WALTHAM Centre for Pet Nutrition
- Waltham-on-the-Wolds
- Petplan Charitable Trust
This publication has 56 references indexed in Scilit:
- Regulation of Blood Pressure and Salt Homeostasis by EndothelinPhysiological Reviews, 2011
- Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2010
- Dopamine and angiotensin as renal counterregulatory systems controlling sodium balanceCurrent Opinion in Nephrology and Hypertension, 2009
- Salt sensitivity in hypertension. Renal and cardiovascular implications.Hypertension, 1994
- Spontaneous Systemic Hypertension in 24 CatsJournal of Veterinary Internal Medicine, 1994
- Activation and measurement of plasma prorenin in the ratCanadian Journal of Physiology and Pharmacology, 1991
- Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.Hypertension, 1983
- CRYOACTIVATION FAILS TO AUGMENT PLASMA RENIN ACTIVITY IN THE CATClinical and Experimental Pharmacology and Physiology, 1982
- Cryoactivation and tryptic activation of blood 'prorenin' in normal man and animalsCanadian Journal of Physiology and Pharmacology, 1978
- Metabolic Studies on Hypertensive Patients with Suppressed Plasma Renin Activity Not Due to HyperaldosteronismCirculation, 1968